ICAAC 2007

Poster Presentations

Molecular Epidemiology and Fungus Testing Laboratory Presentations for the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, September 2007.

• C2-179 Community-Associated Methicillin-Resistant Staphylococcus aureus: An Emerging Cause of Bloodstream Infection (BSI) in Iowa. P. Van de Griend, L. Herwaldt, B. Alvis, M. Demartino, K. Heilmann, G. Doern, P. Winokur, D. Desalvo Vonstein, D. Diekema.
  
  
• C2-207 Serotype Distribution of Streptococcus pneumoniae in the United States. S.S. Richter, K.P. Heilmann, C. Dohrn, F. Riahi, S. Beekmann, G.V. Doern.
  
  
• C2-220 Accuracy of Phenotypic Methods for the Identification of Streptococcus pneumoniae Isolates Included in Surveillance Programs. S.S. Richter, K.P. Heilmann, C. Dohrn, F. Riahi, S. Beekmann, G.V. Doern.
  
  
• M-523 Patterns of Triazole Cross-Resistance/Susceptibility among a Large Collection of Clinical Isolates of Aspergillus. D. J. Diekema, S. Messer, R. Hollis, L. Boyken, S. Tendolkar, J. Kroeger, M. A. Pfaller.
  
  
• M-551 Geographic and Temporal Trends in the Isolation and Antifungal Susceptibility of Candida parapsilosis: A Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program. M. A. Pfaller, D. J. Diekema, D. L. Gibbs, V. A. Newell, K. P. Ng, A. L. Colombo, J. Finquelievich, R. Barnes, J. Wadula.
  
  
• M-552 In Vitro Susceptibility of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance. M. A. Pfaller, L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, D. J. Diekema.
  
  
• M-553 Multicenter Comparison of the VITEK 2 Yeast Susceptibility Test with the CLSI Broth Microdilution Method for Testing Amphotericin B, Flucytosine, and Voriconazole against Candida spp. M. Pfaller, D. Diekema G. Procop, M. Rinaldi.
  
  
• M-554 Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida: Results from a Global Antifungal Surveillance Program. M. A. Pfaller, S. Messer, L. Boyken, S. Tendolkar, J. Kroeger, D. Diekema.
  
  
• M-555 Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis, in Comparison to the Closely-Related Species Candida parapsilosis. S. R. Lockhart, S. A. Messer, S. Tendolkar, M. A. Pfaller, D. J. Diekema.
  
  
• M-1822 Synergy of MG3290, a Histone Deacetylase Inhibitor, with Azoles Tested against Clinical Isolates of Candida and Aspergillus. D. J. Diekema, S. Messer, N. Georgopapadakou, M. A. Pfaller.